Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia. - Wikidata - wikimedia - TriplyDB

Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia.

Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia.

http://www.wikidata.org/entity/Q37613047

about

Development of o -Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors VHL inactivation induces HEF1 and Aurora kinase A Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Mechanisms for nonmitotic activation of Aurora-A at cilia.Bioinformatic prediction and functional characterization of human KIAA0100 gene.3D-QSAR-assisted drug design: identification of a potent quinazoline-based Aurora kinase inhibitor.Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia.

P2860

Q27670770-ED09D756-99D5-46D4-AF50-B75FD2E29874 Q28294037-75AF0501-0D2B-4AEB-8F65-7DE07EC74FF1 Q37242561-FB42D215-46FF-4785-A192-3A0BF1C797EE Q37747066-94E25144-A0F3-4569-A8E8-03E3D0783C04 Q38097334-A326FFFE-D218-4898-BF14-3EDFC851EC40 Q39137312-15D7C670-0090-4C65-AD62-0D71C3A110BB Q50196391-7A1F334E-3FE8-4867-8106-71B1BCC30DCA Q54470261-264E7DF3-8FC1-4FDE-A380-210707C7F1C7 Q54475024-C57B11B3-4258-4C5D-BCF7-2A3EBE519369

P2860

Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia.

http://www.wikidata.org/entity/Q37613047

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@en

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@nl

type

label

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@en

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@nl

prefLabel

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@en

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@nl

P1433

Q37613047-7DFACF7B-512A-40EB-959D-848147AAD431

P1476

Q37613047-1DB940A7-6AA4-4CE1-90E1-A03A359155CA

P2093

Q37613047-4B4289C0-479B-4C15-9463-069701ADC2B8

Q37613047-5E2A83E9-9E06-41CC-96F1-3D1FE29DD40A

Q37613047-C315A9D2-DB67-4F33-82DD-5F9084EFFD16

P2860

Q37613047-0112F4C1-5CB7-4303-827A-66DD2E84CA06

Q37613047-01F62A49-015C-4D68-B89A-6422992F0CEE

Q37613047-050E5A40-424C-4E54-87C6-E0862CF1A7C2

Q37613047-0E56310D-67AB-4C8B-9FF9-C89C3C13C004

Q37613047-1242B60D-CB9C-4F37-8A84-769C201A77EE

Q37613047-14533AC9-BA49-486C-AA11-57269FDF4556

Q37613047-176B8ECD-6485-4C4B-B076-288ECC04C98F

Q37613047-177D4D27-0DD4-4BEF-B2E0-E0BE8C543E52

Q37613047-194085DA-0DAF-4772-A7B5-E369D70E5637

Q37613047-1DB9BAA7-B9A5-4998-BEC4-533C637DBCD6

P304

Q37613047-FFA69DC9-9F91-4E9B-8744-2204C3A95DC0

P31

Q37613047-FB2FF1A0-A0E7-4811-BC53-2E30C08C1FA1

P356

Q37613047-EAAB839C-9285-4295-8C5F-BE686B083C17

P407

Q37613047-B9A5E80C-7100-4A29-B76D-475CEB5EA1AF

P433

Q37613047-F03DFC47-5115-45BB-B12D-3C798BE59145

P478

Q37613047-9BB203D6-14C2-4F04-B9B1-745498172758

P577

Q37613047-ECFCD4B4-AF78-4FD1-B057-F92F89D9E237

P698

Q37613047-2A4BA45B-A7F1-4E57-911B-1955EFC49F2F

P921

Q37613047-34168FAD-85AF-4C5D-9FB9-76844ADFE5CD

Q37613047-F2BF6DA7-A5BB-46A6-9A90-10CD3E18757F

P356

14728220903307483

P1433

Expert Opinion on Therapeutic Targets

P1476

Aurora-A kinase: a novel targe ...... herapy against human leukemia.

@en

P2093

Hiroshi Fujiwara

http://www.w3.org/2001/XMLSchema#string

Masaki Yasukawa

http://www.w3.org/2001/XMLSchema#string

Toshiki Ochi

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner.

Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells

Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP

Cancer immunotherapy: moving beyond current vaccines

Human TPX2 is required for targeting Aurora-A kinase to the spindle

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency

The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin

Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells

P304

1399-1410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728220903307483

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19821797

http://www.w3.org/2001/XMLSchema#string

P921